EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics

Jasbir Bisht iD, Priyanka Rawat, Andrew C Shin iD, Vijay Hegde iD

Cells · 28.05.2026 · 15 (11) · 990

DOI: 10.3390/cells15110990 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 28.05.2026. Verfasst von Jasbir Bisht und 3 weiteren Autor:innen. Beteiligte Einrichtung: Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 166 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the most prevalent form of dementia and is characterized by progressive cognitive decline due to the loss of neurons. The accumulation of extracellular senile plaques (Aβ) and intracellular tau neurofibrillary tangles (NFTs) is a key pathological feature of AD. Mitochondrial dysfunction is implicated in all key AD pathologies, whether as a cause or a consequence of disease progression. Growing evidence indicates that mitochondrial impairment plays a central role in AD pathogenesis by disrupting cellular homeostasis, promoting oxidative stress, and contributing to progressive neuronal death. Therefore, targeting mitochondria may offer promising insights into the development of disease-modifying therapies. In this review, we summarize current evidence on the role of mitochondrial dysfunction in the pathophysiology of AD and on its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMitochondriaHumansOxidative StressAnimalsNeurons

Stichwörter der Autor:innen

Alzheimer’s diseasemitochondrial dysfunctionmitochondrial therapeuticsneurodegenerative diseaseneuronal lossoxidative stress

Autor:innen und Institutionen

  • Obesity and Metabolic Health Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA.
  • Neurobiology of Nutrition Laboratory, Department of Nutritional Sciences, Texas Tech University, Lubbock, TX 79409, USA.

ORCID-Profile: Jasbir Bisht, Andrew C Shin, Vijay Hegde

Förderung

  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Bisht, J., Rawat, P., Shin, A. C., & Hegde, V. (2026). Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics. Cells, 15(11), 990. https://doi.org/10.3390/cells15110990

Vancouver

Bisht J, Rawat P, Shin AC, Hegde V. Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics. Cells. 2026;15(11):990. doi:10.3390/cells15110990

BibTeX
@article{Bisht2026,
  author = {Bisht, Jasbir and Rawat, Priyanka and Shin, Andrew C and Hegde, Vijay},
  title = {Mitochondrial Dysfunction in Alzheimer’s Disease and Mitochondria-Targeted Therapeutics},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {990},
  doi = {10.3390/cells15110990}
}
Kostenlos starten →